These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
391 related articles for article (PubMed ID: 21868791)
1. Gastric bypass surgery enhances glucagon-like peptide 1-stimulated postprandial insulin secretion in humans. Salehi M; Prigeon RL; D'Alessio DA Diabetes; 2011 Sep; 60(9):2308-14. PubMed ID: 21868791 [TBL] [Abstract][Full Text] [Related]
2. Blockade of glucagon-like peptide 1 receptor corrects postprandial hypoglycemia after gastric bypass. Salehi M; Gastaldelli A; D'Alessio DA Gastroenterology; 2014 Mar; 146(3):669-680.e2. PubMed ID: 24315990 [TBL] [Abstract][Full Text] [Related]
3. Altered islet function and insulin clearance cause hyperinsulinemia in gastric bypass patients with symptoms of postprandial hypoglycemia. Salehi M; Gastaldelli A; D'Alessio DA J Clin Endocrinol Metab; 2014 Jun; 99(6):2008-17. PubMed ID: 24617664 [TBL] [Abstract][Full Text] [Related]
4. Differential effect of endogenous glucagon-like peptide-1 on prandial glucose counterregulatory response to hypoglycaemia in humans with and without bariatric surgery. Honka H; Gastaldelli A; Pezzica S; Peterson R; DeFronzo R; Salehi M Diabetes Obes Metab; 2024 Jun; 26(6):2476-2486. PubMed ID: 38558527 [TBL] [Abstract][Full Text] [Related]
5. Effect of endogenous GLP-1 on insulin secretion in type 2 diabetes. Salehi M; Aulinger B; Prigeon RL; D'Alessio DA Diabetes; 2010 Jun; 59(6):1330-7. PubMed ID: 20215429 [TBL] [Abstract][Full Text] [Related]
6. Roles of increased glycaemic variability, GLP-1 and glucagon in hypoglycaemia after Roux-en-Y gastric bypass. Tharakan G; Behary P; Wewer Albrechtsen NJ; Chahal H; Kenkre J; Miras AD; Ahmed AR; Holst JJ; Bloom SR; Tan T Eur J Endocrinol; 2017 Dec; 177(6):455-464. PubMed ID: 28855269 [TBL] [Abstract][Full Text] [Related]
7. Postprandial gut hormone responses and glucose metabolism in cholecystectomized patients. Sonne DP; Hare KJ; Martens P; Rehfeld JF; Holst JJ; Vilsbøll T; Knop FK Am J Physiol Gastrointest Liver Physiol; 2013 Feb; 304(4):G413-9. PubMed ID: 23275610 [TBL] [Abstract][Full Text] [Related]
8. Altered glucose metabolism after bariatric surgery: What's GLP-1 got to do with it? Smith EP; Polanco G; Yaqub A; Salehi M Metabolism; 2018 Jun; 83():159-166. PubMed ID: 29113813 [TBL] [Abstract][Full Text] [Related]
9. Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal. Goldfine AB; Mun EC; Devine E; Bernier R; Baz-Hecht M; Jones DB; Schneider BE; Holst JJ; Patti ME J Clin Endocrinol Metab; 2007 Dec; 92(12):4678-85. PubMed ID: 17895322 [TBL] [Abstract][Full Text] [Related]
11. Increased postprandial GIP and glucagon responses, but unaltered GLP-1 response after intervention with steroid hormone, relative physical inactivity, and high-calorie diet in healthy subjects. Hansen KB; Vilsbøll T; Bagger JI; Holst JJ; Knop FK J Clin Endocrinol Metab; 2011 Feb; 96(2):447-53. PubMed ID: 21047927 [TBL] [Abstract][Full Text] [Related]
12. Hyperinsulinemic hypoglycemia after Roux-en-Y gastric bypass: unraveling the role of gut hormonal and pancreatic endocrine dysfunction. Rabiee A; Magruder JT; Salas-Carrillo R; Carlson O; Egan JM; Askin FB; Elahi D; Andersen DK J Surg Res; 2011 May; 167(2):199-205. PubMed ID: 21414635 [TBL] [Abstract][Full Text] [Related]
13. Both GLP-1 and GIP are insulinotropic at basal and postprandial glucose levels and contribute nearly equally to the incretin effect of a meal in healthy subjects. Vilsbøll T; Krarup T; Madsbad S; Holst JJ Regul Pept; 2003 Jul; 114(2-3):115-21. PubMed ID: 12832099 [TBL] [Abstract][Full Text] [Related]
14. Antidiabetic actions of endogenous and exogenous GLP-1 in type 1 diabetic patients with and without residual β-cell function. Kielgast U; Holst JJ; Madsbad S Diabetes; 2011 May; 60(5):1599-607. PubMed ID: 21441444 [TBL] [Abstract][Full Text] [Related]
15. A Potential Role for Endogenous Glucagon in Preventing Post-Bariatric Hypoglycemia. Lobato CB; Pereira SS; Guimarães M; Hartmann B; Wewer Albrechtsen NJ; Hilsted L; Holst JJ; Nora M; Monteiro MP Front Endocrinol (Lausanne); 2020; 11():608248. PubMed ID: 33424773 [TBL] [Abstract][Full Text] [Related]
16. Endogenous glucagon-like peptide 1 controls endocrine pancreatic secretion and antro-pyloro-duodenal motility in humans. Schirra J; Nicolaus M; Roggel R; Katschinski M; Storr M; Woerle HJ; Göke B Gut; 2006 Feb; 55(2):243-51. PubMed ID: 15985560 [TBL] [Abstract][Full Text] [Related]
17. Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in non-diabetic subjects. Jacobsen SH; Olesen SC; Dirksen C; Jørgensen NB; Bojsen-Møller KN; Kielgast U; Worm D; Almdal T; Naver LS; Hvolris LE; Rehfeld JF; Wulff BS; Clausen TR; Hansen DL; Holst JJ; Madsbad S Obes Surg; 2012 Jul; 22(7):1084-96. PubMed ID: 22359255 [TBL] [Abstract][Full Text] [Related]
18. Evidence from a single individual that increased plasma GLP-1 and GLP-1-stimulated insulin secretion after gastric bypass are independent of foregut exclusion. Salehi M; Gastaldelli A; D'Alessio DA Diabetologia; 2014 Jul; 57(7):1495-9. PubMed ID: 24797288 [No Abstract] [Full Text] [Related]
20. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus. Vilsbøll T; Krarup T; Sonne J; Madsbad S; Vølund A; Juul AG; Holst JJ J Clin Endocrinol Metab; 2003 Jun; 88(6):2706-13. PubMed ID: 12788877 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]